Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03461718 · ClinicalTrials.gov registry record · Phase 2
Ketamine for Endoscopic Sedation in Outpatient Adult Endoscopy.
A Phase 2 study, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT03461718: Completed Phase 2 study, sponsored by Brooke Army Medical Center.
NCT03461718 is a Phase 2 study that has completed, run by Brooke Army Medical Center. The registered enrollment target is 66 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03461718, a Phase 2 study, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
We will be investigating the use of ketamine in sedation for endoscopic procedures, specifically outpatient endoscopy including esophagoduodenoscopy (EGD) and colonoscopy. Participants will be randomized to one of two arms including conventional moderate sedation with midazolam and fentanyl or the ketamine arm. They will then undergo the planned procedure. Physicians preforming the procedure will be surveyed following the procedure and patients will be surveyed twice, once after meeting criteria for discharge on day of the procedure and a second time 48 hours following the procedure.
Primary Outcome
Measured with CSSI score. This consists of a questionnaire administered to the provider following the procedure with questions detailing different aspects of the procedure. Answers will be summed and the scores are normalized to a scale of 0-100 (high scores denote higher satisfaction).
Interventions
- DRUG Ketamine
- DRUG Fentanyl
- DRUG Midazolam injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2019-10-01 |
| Phase | Phase 2 |
What the finished NCT03461718 record still lists
NCT03461718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 3 interventions - of which Ketamine is the first listed.
NCT03461718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03461718 about?
NCT03461718 is a clinical study titled "Ketamine for Endoscopic Sedation in Outpatient Adult Endoscopy.". We will be investigating the use of ketamine in sedation for endoscopic procedures, specifically outpatient endoscopy including esophagoduodenoscopy (EGD) and colonoscopy. Participants will be randomized to one of two arms including conventional moderate sedation with midazolam and fentanyl or the k...
What is the current status of trial NCT03461718?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2018-03-05. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT03461718?
The interventions under investigation include: Ketamine (DRUG), Fentanyl (DRUG), Midazolam injection (DRUG).
Who is sponsoring clinical trial NCT03461718?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03461718's enrollment target sits among peer trials
66 975th of 2000 higher than 1,014 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI